Survival in patients with CKD 3-5 after 12 months of exercise training - a post-hoc analysis of the RENEXC trial

被引:0
|
作者
Denguir, Sara [1 ,2 ]
Hellberg, Matthias [1 ,2 ]
Almquist, Martin [2 ,3 ]
Clyne, Naomi [1 ,2 ]
机构
[1] Skane Univ Hosp, Fac Med, Dept Nephrol, Dept Clin Sci Lund, Lund, Sweden
[2] Lund Univ, Lund, Sweden
[3] Skane Univ Hosp, Fac Med, Dept Surg, Dept Clin Sci Lund, Lund, Sweden
关键词
Chronic kidney disease; Physical performance; Physical activity; Exercise training; 6-Minute walking test; Sit-To-Stand test; Handgrip test; Mortality; Survival; CHRONIC KIDNEY-DISEASE; ALL-CAUSE MORTALITY; GLOMERULAR-FILTRATION-RATE; PHYSICAL-ACTIVITY; AMBULATORY PATIENTS; SECONDARY ANALYSIS; CLINICAL-OUTCOMES; DIALYSIS PATIENTS; ASSOCIATION; HEMODIALYSIS;
D O I
10.1186/s12882-024-03915-1
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
BackgroundPhysical performance is low and physical activity declines in people with chronic kidney disease (CKD). Both factors are associated with decreased survival. Our hypothesis was that improved physical performance after 12 months of exercise training would result in better survival in patients with CKD stages 3 to 5 not on kidney replacement therapy (KRT). Our aims in this study were to investigate the survival effects of (1) baseline physical performance and (2) physical performance after 12 months of exercise training.MethodsThis is a post-hoc analysis of the RENEXC trial, a randomized controlled study comparing 12 months of strength- and balance training both in combination with aerobic training. Both groups improved physical performance with no between group differences. Patients were categorized into five groups: improved >= 5%, unchanged, deteriorated >= 5%, non-completers, missing data. Univariate and multivariate Cox regression analyses were used and adjusted for age, sex, comorbidity, time on dialysis and time with a kidney transplant.Results151 patients participated, mean age 66 +/- 14 years, 65% men, eGFR 22.5 +/- 8.2 ml/min/1.73m2, average follow-up 60 months.Multivariate analysesThe baseline 6-minute walk test (6MWT) (HR 0.996; 95% CI [0.993-0.998]) and 30-second sit-to-stand (30s-STS) (HR 0.94 CI [0.89-1.0]) were positively associated with survival. After 12 months of exercise improved handgrip strength (HGS) right (HR 2.66; 95% CI [1.07-6.59]) was associated with better survival compared with deterioration. Improvement compared with noncompletion was associated with better survival (6MWT (HR 2.88; 95% CI [1.4-5.88]), HGS right (HR 4.44; 95% CI [1.79-10.98]), functional reach (HR 3.69; 95% CI [1.82-7.48]), isometric quadriceps strength right (HR 2.86; 95% CI [1.43-5.72]), 30s-STS (HR 3.44; 95% CI [1.66-7.11]).ConclusionBaseline walking distance, muscular strength and endurance in the legs were independently associated with survival in people with CKD stages 3-5 without KRT. After completing 12 months of exercise training improved walking distance, muscular strength and endurance, and balance were positively associated with survival, compared with noncompleters. Better physical performance at baseline and the ability to complete 12 months of exercise training conferred survival benefits. There are probably several factors affecting better survival. These factors require elucidation in future studies.Trial registrationClinicalTrials.gov NCT02041156. Registration date 20,240,107.
引用
收藏
页数:8
相关论文
共 50 条
  • [11] Remission At 3 Or 6 Months and Radiographic Non-Progression At 12 Months In Methotrexate-Naive Rheumatoid Arthritis Patients Treated With Tofacitinib Or Methotrexate: A Post-Hoc Analysis Of The ORAL Start Trial
    Strand, V.
    van der Heijde, D.
    Landewe, R.
    Lee, E. B.
    Wilkinson, B.
    Zwillich, S. H.
    Bradley, J.
    Mebus, C.
    Benda, B.
    Gruben, D.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S842 - S843
  • [12] Effect of Ziltivekimab on Determinants of Hemoglobin in Patients with CKD Stage 3-5: An Analysis of a Randomized Trial (RESCUE)
    Pergola, Pablo E.
    Davidson, Michael
    Jensen, Camilla
    Zonoozi, Amir A. Mohseni
    Raj, Dominic S.
    Schytz, Philip Andreas
    Tuttle, Katherine R.
    Perkovic, Vlado
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (01): : 74 - 84
  • [13] Repeat revascularization impact on 10-year survival after PCI or CABG: post-hoc analysis of the SYNTAXES trial
    Lunardi, M.
    Ono, M.
    Onuma, Y.
    Serruys, P.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2111 - 2111
  • [14] Dapagliflozin Effect on Hospital Admissions in Patients With CKD: A Post Hoc Analysis of the DAPA-CKD Trial
    Schechter, Meir
    Jongs, Niels
    Chertow, Glenn
    Mosenzon, Ofri
    McMurray, John
    Correa-Rotter, Ricardo
    Rossing, Peter
    Langkilde, Anna Maria
    Sjostrom, David
    Toto, Robert D.
    Wheeler, David C.
    Heerspink, Hiddo J. L.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 25 - 25
  • [15] Effects of exercise on residual renal function in patients undergoing peritoneal dialysis: A post-hoc analysis of a randomized controlled trial
    Uchiyama, Kiyotaka
    Washida, Naoki
    Morimoto, Kohkichi
    Muraoka, Kaori
    Nakayama, Takashin
    Adachi, Keika
    Kasai, Takahiro
    Miyashita, Kazutoshi
    Wakino, Shu
    Itoh, Hiroshi
    THERAPEUTIC APHERESIS AND DIALYSIS, 2020, 24 (06) : 668 - 676
  • [16] Adverse Events During and After Early Mobilization: A Post-hoc Analysis of the TEAM Trial
    Broadley, T.
    Higgins, A. M.
    Hodgson, C. L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [17] Effect of KRASG12 mutations on overall survival in patients with refractory metastatic colorectal cancer: A post-hoc analysis of the phase III SUNLIGHT trial
    Tabernero, J.
    Prager, G.
    Fakih, M.
    Ciardiello, F.
    Van Cutsem, E.
    Elez Fernandez, M. E.
    Cruz, F. J. S. M.
    Wyrwicz, L. S.
    Stroyakovskiy, D.
    Papai, Z.
    Martinelli, E.
    Salvatore, L.
    Poureau, P. G.
    Liposits, G.
    Cremolini, C.
    Modest, D. P.
    Causse-Amellal, N.
    Roby, L.
    Skanji, D.
    Taieb, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S440 - S441
  • [18] EFFECTS OF 1-YEAR SELF-ADMINISTERED EXERCISE ON PHYSICAL PERFORMANCE IN CKD 3B-5-THE RENEXC TRIAL
    Hellberg, Matthias
    Svensson, Philippa
    Hoglund, Peter
    Clyne, Naomi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 603 - 603
  • [19] Bone mineral density after exercise training in patients with chronic kidney disease stages 3 to 5: a sub-study of RENEXC-a randomized controlled trial
    Petrauskiene, Vaida
    Hellberg, Matthias
    Svensson, Philippa
    Zhou, Yunan
    Clyne, Naomi
    CLINICAL KIDNEY JOURNAL, 2024, 17 (01)
  • [20] SURVIVAL AND PLEURODESIS OUTCOME IN PATIENTS WITH MALIGNANT PLEURAL EFFUSION - POST-HOC ANALYSIS FROM THE TIME-1 TRIAL
    Hassan, M.
    Mercer, R. M.
    Maskell, N.
    Pepperell, J.
    Saba, T.
    Ali, N.
    West, A.
    Miller, R. F.
    Hallifax, R. J.
    Corcoran, J. P.
    Asciak, R.
    McCracken, D.
    Bedawi, E. O.
    Rahman, N. M.
    THORAX, 2018, 73 : A82 - A83